(Q53666804)

17 May 2018

title

HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma. (English)

1 reference

17 May 2018

author

Ingrid Fleming

5

1 reference

17 May 2018

Bernhard Brüne

8

Bernhard Brüne

1 reference

17 May 2018

Nathalie Dehne

7

Nathalie Dehne

1 reference

17 May 2018

Theresa Geis

1

Theresa Geis

1 reference

17 May 2018

Nina Grossmann

4

Nina Grossmann

1 reference

17 May 2018

Rüdiger Popp

3

Rüdiger Popp

1 reference

17 May 2018

Claudia Döring

2

Claudia Döring

1 reference

17 May 2018

author name string

Martin-Leo Hansmann

6

1 reference

17 May 2018

language of work or name

English

0 references

publication date

6 December 2014

1 reference

17 May 2018

Experimental Cell Research

published in

1 reference

17 May 2018

volume

331

1 reference

17 May 2018

issue

1

1 reference

17 May 2018

page(s)

46-57

1 reference

17 May 2018

Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Identification and characterization of a novel prespheroid 3-dimensional hepatocyte monolayer on galactosylated substratum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Bioconductor: open software development for computational biology and bioinformatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Hypoxia-inducible factors in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Control of leucocyte differentiation from embryonic stem cells upon vasculogenesis and confrontation with tumour tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

More powerful procedures for multiple significance testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Generation of a novel proteolysis resistant vascular endothelial growth factor165 variant by a site-directed mutation at the plasmin sensitive cleavage site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Hypoxia-inducible factors and the response to hypoxic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

The role of hypoxia-inducible factors in tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Serum-derived plasminogen is activated by apoptotic cells and promotes their phagocytic clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Cardiac specific differentiation of mouse embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

HIF-1 and mechanisms of hypoxia sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

HIF-1alpha versus HIF-2alpha in endothelial cells and vascular functions: is there a master in angiogenesis regulation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Three-dimensional growth as multicellular spheroid activates the proangiogenic phenotype of colorectal carcinoma cells via LFA-1-dependent VEGF: implications on hepatic micrometastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Vascular changes in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.018

10.1016/J.YEXCR.2014.11.018

7 January 2021

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018